期刊文献+

加快顺式阿曲库铵全麻诱导起效的临床研究 被引量:5

Clinical research on acceleration of onset time of Cisatracurium in general anesthesia induction
下载PDF
导出
摘要 目的本研究以3ED95顺式阿曲库铵分别联合不同低剂量阿曲库铵用于麻醉诱导,与单独使用3ED95和4ED95顺式阿曲库铵比较,旨在探索联合用药加快起效时间的临床效应。方法选择ASA分级I-Ⅱ级,需全麻下手术的患者80例,随机分为4组。A组,顺式阿曲库铵0.15 mg/kg;B组,顺式阿曲库铵0.20mg/kg;C组,顺式阿曲库铵0.15 mg/kg联合阿曲库铵0.10 mg/kg;D组,顺式阿曲库铵0.15 mg/kg联合阿曲库铵0.20 mg/kg。使用肌松监测仪进行拇内收肌肌松监测,诱导均采用咪唑安定0.05 mg/kg,芬太尼4 ug/kg,依托咪酯0.3 mg/kg,T1/Tc<10%时气管插管。记录各组肌松效应起效时间、插管条件评级及MAP、HR、SpO2变化。结果各组患者插管条件及相应时间点血液动力学参数无统计学差异。B、C、D组起效时间加快,其中C、D组与A组比较有统计学差异(P<0.05),B组虽起效时间短于A组,但无统计学差异(P>0.05)。结论 3ED95顺式阿曲库铵联合少量的阿曲库铵可以显著缩短起效时间,效果优于4ED95顺式阿曲库铵,不影响血液动力学参数,更有利于全麻气管插管的应用。 [ Objective ] To compare the onset time of co-administration of 3ED95 (0.15 mg/kg) cisatracurium and different low doses of atracurium in general anesthesia induction with 3ED95 and 4ED95 cisatracurium respectively. So as to explore the clinical effect of drug combination for accelerating the onset time of cisatracurium. [Methods] 80 patients classified ASA Ⅰ-Ⅱ undergoing elective general anesthesia were randomly divided into 4 groups(n =20): group A received cisatracurium 0.15 mg/kg, group B received cisatracurium 0.20 mg/kg, group C received cisatracurium 0.15 mg/kg combined with atracurium 0.10 mg/kg, and group D received cisatracurium 0.15 mg/kg combined with atracurium 0.20 mg/kg. Neuromuscular block at adductor pollicis was monitored by a TOF-Watch SX accelerograph. Anesthesia was induced with midazolam 0.05 mg/kg, fentanyl 5 ug/kg, etomidate 0.3 mg/kg and the corresponding doses of muscle relaxants. Intubation was attempted after the first twitch height became less than 10% of baseline. The onset time (was from end of bolus injection to 100% twitch depression), intubation conditions and changes of MAP, HR, SPO2 were recorded. [ Results ] There was no significant difference in intubation conditions, MAP, HR or SPO2 among the 4 groups. The onset time was significantly shorter in group C and D than in group A (P 〈0.05) but there was no significant difference between group B and A (P 〉0.05). [ Conclusion] Co-administration of 3ED95 cisatracurium and low doses of atracurium can accelerate the onset time without hemodynamic instability. Co-administration of two muscle relaxants is more effective than single usage of muscle relaxant.
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2012年第3期63-65,共3页 China Journal of Modern Medicine
关键词 顺式阿曲库铵 阿曲库铵 起效时间 Cisatracurium atracurium onset time
  • 相关文献

参考文献8

  • 1莫利求,黄文起,谭洁芳.新的中效肌松药——顺式阿曲库铵[J].国外医学(麻醉学与复苏分册),2000,21(3):170-172. 被引量:31
  • 2SONG FH,GU MN,LI CX,et al.Clinical observation of effect of prim-ing principle on the onset time of cisatracurium[J].Guangdong MedicalJournal,2011,32(4):454-456.
  • 3ABDULLA WY.The synergistic effect of 2 different nondepolarizingmuscle-relaxants on intraocular-pressure[J].J Clin Anesth,1993,5(1):5-11.
  • 4LEE C.Structure,conformation,and action of neuromuscular blockingdrugs[J].Br J Anaesth,2001,87(5):755-769.
  • 5KIROV K,MONTAMED C,DECAILLIOT F,et al.Comparison of theneuromuscular blocking effect of cisatracurium and atracurium on thelarynx and the adductor pollicis[J].Acta Anaesthesiol Scand,2004,48(5):577-581.
  • 6罗慧,郭曲练,王锷.顺式阿曲库铵在肥胖患者中的应用[J].中国现代医学杂志,2010,20(9):1394-1396. 被引量:5
  • 7BERGERON L,BEVAN DR,BERRILL A,et al.Concentration-ef-fect relationship of cisatracurium at three different dose levels in theanesthetized patient[J].Anesthesiology,2001,95:314-323.
  • 8NIGROVIC V,AMANN A.Simulation of interaction between twonon-depolarizing muscle relaxants:generation of an additive or asupra-additive neuromuscular block[J].Journal of Pharmacokineticsand Pharmacodynamics,2004,31:157-179.

二级参考文献21

  • 1FUCHS-BUDER T, CLAUDIUS C, SKOVGAARD LT, et al. Good clinical research practice in phannacodynamic studies of neuromuscular blocking agents II: the Stockholm revision[J]. Acta Anaesthesiologiea Scandinavica. 2007, 51(7): 789-808.
  • 2KIROV K, MONTAMED C, DECAILLIOT F, et al. Comparison of the neuromuscular blocking effect of cisatracurium and atracurium on the larynx and the adductor poUicis[J]. Acta Anaesthesiol Stand, 2004, 48 (5): 577-581.
  • 3World Health Organization. Report of a WHO consultation on obesity: preventing and managing the global epidemic [R]. Geneva: World Health Organization, 1997: 1.
  • 4OLKKOLA KT, TAMMISTO T. Quantifying the interaction of rocuronium (Org 9426) with etomidate, fentanyl, midazolam, propofol, thiopental, and isoflurane using closed-loop feedback oontrol of roouronium infusion[J]. Anesth Analg, 1994, 78(4):691-696.
  • 5KIRKEGAARD-NIELSEN H, HELBOHANSEN HS, LINDHOLM P, et al. Anthropometrle variables as predictors for duration of action of atracurium-induced neuromuscular block[J]. Ancsth Analg, 1996,83(5): 1076-1080.
  • 6KISOR DF, SCHMITH VD. Clinical pharmacokinetics of cisatracurium besilate[J]. Clinical Pharmacokinetics, 1999, 36(1): 27-40.
  • 7SCHMIT VD, FIEDLERKELLY J, PHILLIPS L, et al. Prospective use of population pharmaeokinetics/pharmaeodynamics in the development of cisatracurium[J]. 1997, 14(1):91-97.
  • 8LEYKIN Y, PELLIS T, LUCCA M, et al. The effects of cisatracurium on morbidly obese women[J]. Anesth Analg. 2004, 99(4):1090-1094.
  • 9LI JQ, DUAN FM, WANG CY, et al. The dose-effectrelationship of vecuronium on obese patients when administered on lean body weight [J]. The journal of clinical aneshtesiology, 2009, 25(3): 265-266.
  • 10MILLER R. Anaesthesia [M]. Philadelphia: ChurehiU Livingstone, 2000: 412- 490.

共引文献34

同被引文献38

  • 1魏嵘,杜晶慧,付月珍,金泉英.顺式阿曲库铵在儿童早期插管中的应用研究[J].上海交通大学学报(医学版),2011,31(11):1625-1627. 被引量:4
  • 2庄心良,主编.现代麻醉学[M].第3版.北京:人民卫生出版社,2009.1292-1295.
  • 3de Wit M, Pedram S, Best AM, et al. Observational study of patient - ventilator asynchrony and relationship to sedation level [ J ]. J Crit Care, 2009, 24 (1): 74-80.
  • 4Jeong HJ, Lee SH, Kim HJ, et al. Effects on intubating conditions of pretreatment with remifentanil before administration of cisatracurium [J]. ChonnamMedJ, 2012, 48 (2): 96 -102.
  • 5Linstedt U, Haecker KG, Prengel AW. Light levels of anaesthesia after relaxation for tracheal intubation - comparison of succinylcholine and cis -atracurium [J]. Acta Anaesthesiol Scand, 2012, 56 (6): 762- 769.
  • 6Carteaux G, Lyazidi A, Cordoba - Izquierdo A, et al. Patient - ventila- tor asynchrony during noninvasive ventilation : a bench and clinical study [J]. Chest, 2012, 142 (2): 367-376.
  • 7Pierson DJ. Patient - ventilator interaction [ J]. Respir Care, 2011, 56 (2): 214-228.
  • 8Liu M, Dilger JP. Synergy between pairs of competitive antagonists at a- dult human muscle acetylcholine receptors [J].Anesth Analg, 2008, 107 (2) : 525 -533.
  • 9Lagneau F. Indications and uses of neuromuscular blocking agents in the ICU [J]. Ann Fr Anesth Reanim, 2008, 27 (7/8) : 567 -573.
  • 10Chabanne R, Colomb S, Gonzalez D, et al. Use of neuromuscular blocking agents in prehospital medicine: practice survey in Emergency Mobile Services of the South - East of France [J]. Ann Fr Anesth Reanim, 2011, 30 (9): 636-640.

引证文献5

二级引证文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部